TETANUS TOXOID ADSORBED Rx
Generic Name and Formulations:
Tetanus toxoid; aluminum adsorbed; susp for IM inj; multi-dose vial preserved with thimerosal, single-dose vials contain trace amounts of thimerosal.
Sanofi Pasteur, Inc.
Indications for TETANUS TOXOID ADSORBED:
Adults and Children:
<7yrs: not recommended. Give IM in anterolateral thigh or deltoid. ≥7yrs: Previously unvaccinated: three 0.5mL doses at elected date, then 4–8 weeks after first dose, and 6–12 months after second dose. Give booster dose at 11–12 yrs of age if last dose of tetanus and diphtheria toxoid-containing vaccine was given ≥5yrs ago. Other: give booster every 10 years.
Latex allergy. Previous arthus-type hypersensitivity reaction: do not give more frequently than every 10 years. Defer in moderate or severe active respiratory or other febrile infection (may vaccinate if mild or minor illness) or during polio outbreak. Guillain-Barre syndrome within 6 weeks of last tetanus vaccine. Bleeding disorders. Immunosuppressed. Have epinephrine (1:1000) available. Elderly. Pregnancy (Cat.C). Nursing mothers.
May get suboptimal response with immunosuppressants (eg, chemotherapy, high dose corticosteroids ≥2 weeks, radiation); consider deferring.
Local reactions (eg, erythema, tenderness), malaise, fever, hypotension, pain, nausea, arthralgia; rare: neurological disorders.
Single-dose vials (latex free)—10
Multi-dose vial (5mL)—1
Neurology Advisor Articles
- Some Statins May Be Associated With Cognition, Memory Deficits
- Neuropathic Pain Treatments
- New Monoclonal Antibody BAN2401 Reduces Amyloid Plaques, Improves Cognition in Alzheimer's
- Nonpharmacologic Interventions for Alzheimer's Have Greater Impact on Outcomes Than Currently Available Medications
- Vagus Nerve Stimulation in Pediatric Epilepsy: Weighing the Risks and Benefits
- Court Rules That U.S. Must Halt Sales of Pesticide Chlorpyrifos
- Both Abstinence and High Alcohol Use Linked to Dementia
- Therapeutic Plasma Exchange Effectively Improves Ambulation in Pediatric Transverse Myelitis
- TBI Linked to Increased Suicide Risk
- OnabotulinumtoxinA for Post-Stroke Spasticity: Treatment Strategies and Limitations